|
HS Code |
875092 |
| Iupac Name | 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid |
| Molecular Formula | C9H7N3O2 |
| Molecular Weight | 189.17 g/mol |
| Cas Number | 147873-09-6 |
| Appearance | Off-white to light yellow powder |
| Melting Point | 235-240°C |
| Solubility In Water | Slightly soluble |
| Smiles | C1=CN=CN1C2=NC=C(C=C2)C(=O)O |
| Inchi | InChI=1S/C9H7N3O2/c13-9(14)7-2-3-8(10-6-7)12-4-1-5-11-12/h1-6H,(H,13,14) |
| Pka | Approx. 4.8 (carboxylic acid group) |
| Pubchem Cid | 12938203 |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
As an accredited 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle containing 25 grams of 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid, labeled with safety and chemical information. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with securely packed 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid in sealed, labeled drums or cartons. |
| Shipping | 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid is shipped in tightly sealed containers, protected from light and moisture. It is packaged to prevent leaks or contamination and complies with relevant chemical transport regulations. Handling instructions and safety data accompany the shipment to ensure safe storage and use upon delivery. |
| Storage | 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid should be stored in a tightly sealed container, protected from light, moisture, and incompatible substances. Store at room temperature (15–25°C) in a cool, dry, well-ventilated area designated for chemicals. Avoid exposure to extreme temperatures and keep away from strong acids, bases, and oxidizing agents. Ensure containers are clearly labeled and securely closed when not in use. |
| Shelf Life | 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid has a typical shelf life of 2–3 years if stored cool, dry, and protected from light. |
|
Purity 99%: 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid with purity 99% is used in pharmaceutical intermediate synthesis, where it ensures high product yield and consistency. Melting point 202°C: 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid with melting point 202°C is used in solid-state formulation development, where it provides improved thermal stability in processing. Molecular weight 189.17 g/mol: 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid with molecular weight 189.17 g/mol is used in lead compound discovery trials, where it enables accurate dosing and pharmacokinetic studies. Stability temperature up to 120°C: 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid with stability temperature up to 120°C is used in high-temperature catalysis research, where it maintains structural integrity during reactions. Particle size <10 µm: 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid with particle size less than 10 µm is used in fine chemical formulations, where it allows for enhanced dissolution rates and homogeneous mixing. |
Competitive 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Decades of hands-on experience in chemical manufacturing teach you to recognize molecules with promising value. Among the compounds synthesized and refined in our reactor halls, 6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid stands out for its reliable performance in specialized laboratory and industrial research. We receive inquiries from research teams focused on diverse projects—organometallic catalysis, medicinal chemistry, heterocycle synthesis—often turning to this molecule for its distinct combination of imidazole-linked pyridine structure with a carboxyl functionality. As manufacturers, we approach each batch with sustained attention to purity, cost, and supply consistency because those directly affect the outputs of our stakeholders.
We don’t run production on autopilot. Purity above 98% comes from disciplined routine QC, sophisticated analytic verification, and a short supply chain that allows responsive adjustments. Most batches are white-to-pale beige crystalline powder. Moisture content, trace metal levels, and residue-solvent testing matter to us because they affect downstream reactions, and small labs or large facilities expect reproducible results—not unexplained by-products or deviations.
Customer feedback shaped our filtration and drying routines. Several years ago, a pilot client studying medicinal analogs flagged interference during NMR analysis. We found out residual polar by-products were getting through an old filter bed. By overhauling the silica grade and re-tuning the solvent system, we cut interfering signatures below detectable thresholds, improving crystallinity and minimizing customer troubleshooting time. Such improvements don’t show up in specs sheets; they become evident during real-world workups and bioactivity screening. That practice brings repeat clients—not certificates.
The 6-(1H-imidazol-1-yl)pyridine motif combines two relevant heterocycles with a carboxylic acid at a position granting good reactivity in further couplings or salt formation. That makes it a frequent scaffold or intermediate in synthesis programs for pharmaceuticals, sensors, and coordination chemistry. Conventional pyridine carboxylic acids or simple imidazole derivatives each lack the same reactivity profile for metal complexation and ring fusion studies. This molecule grants access to a broader chemistry—through the acid group, which handles amidation, esterification, or metal chelation, and through the nitrogen atoms, which unlock supramolecular interaction or ligation options.
We've seen labs leverage this advantage in transition metal catalysis, producing ligands unreliant on toxic phosphorous or highly basic reagents. Others exploit its imidazole core for developing proton transfer systems or functional polymers. The solubility profile—moderate in polar organic solvents, limited in water—matches the requirements for reaction scale-ups, especially when downstream isolation counts. These differences might sound technical, but lost yield from solubility mismatch, for example, can set research budgets back by weeks. Experience teaches you to pick the molecule that fits not only the experiment’s theory, but also practical workflows.
We routinely offer this product in lots tailored for research and process development, scaling from 25 g sample jars to multi-kilogram lined containers. Particle size, batch homogeneity, and storage stability are all validated before release, because we’ve witnessed how an overlooked lot, left to degrade in transit, lost viability for a pharma scale-up and caused weeks of reordering for the client. Our packing is sealed, light-stable, and includes tamper tags—borne directly from prior theft attempts and moisture ingress on low-quality packaging we encountered years ago.
Handling guidelines reflect real-world use and regulatory feedback rather than generic best practices. Temperatures above 40°C degrade this acid faster—thermal history can show up as yellowing. Some batches destined for European regulatory jurisdictions require extra purity documentation regarding nitrosamine absence, since newer compliance frameworks regard these trace contaminants with increased scrutiny; we audit for such contaminants batchwise using sensitive LC-MS techniques.
The process routes we use—either direct coupling from imidazole with pre-activated pyridine carboxylic acid, or cyclization from amidinated precursors—are refined for maximum selectivity. Years of optimization minimized side reactions common among imidazole-pyridine systems, and we routinely review solvent recycling and waste neutralization because local regulations evolve. Our facility includes in-line monitoring that tracks pH, oxidation state, and residue solvent content on output, though we still reserve old-fashioned TLC and melting-point checks for each batch, since those catch batch-to-batch inconsistencies faster than the fanciest instrument.
We don’t operate in the abstract. Our clients tell us their pain points using related compounds—limited selectivity, unpredictable solubility, poor stability in storage, or regulatory headaches. The carboxylic acid at the pyridine ring’s 3-position allows direct application in drug design and chemical ligation. Medicinal chemists need durability and compatibility with peptide coupling agents or bio-relevant buffers. Some research groups integrate the compound into metal-organic frameworks due to the dual chelating nitrogen-acid motif. In specialty polymer chemistry, the fused heterocycle system enhances electronic communication, offering distinct conductivity profiles in models for advanced materials.
We receive direct input from development teams needing to modify the core structure for SAR (Structure–Activity Relationship) studies. Quick turnarounds and assured purity mean fewer surprises with late-stage candidate qualification. On the industrial end, reliability in physical form and solubility speeds up filtration, isolation, and downstream processing. The body of published work has grown as researchers cite our batch traceability alongside project outcomes—not just literature references without concrete origin.
We often field questions about why this molecule outperforms close relatives—such as 2-pyridinecarboxylic acids, or isomers bearing the carboxyl at other positions. The 6-(1H-imidazol-1-yl) substitution grants both an electronic effect (increasing acidity at the carboxyl) and new angles for hydrogen bonding and metallic coordination. This translates to higher coupling yields for bioconjugations, as well as improved shelf-life versus more reactive but unstable analogs. Customers who once bought basic imidazole derivatives with separate pyridine coupling steps now streamline syntheses, cutting several days from their development cycle.
A common case involves metal complexes for catalytic screening—researchers report that the bidentate environment from joined nitrogens in this molecule offers greater catalyst stability than when using an analogous imidazole-pyridine mixture. Polymer scientists find that the substitution pattern tunes electron transfer differently compared to more symmetrical imidazole adducts, yielding polymers with controllable photophysical characteristics. The main differences aren’t just theoretical—they show up in reaction tolerability and the clean-up process, especially during sensitive multistep syntheses where separating by-products eats into project timelines.
From our earliest runs through today’s larger-scale campaigns, we treat user feedback as an actionable metric rather than an afterthought. In several instances, pharmaceutical companies provided input highlighting undetectable impurities that tainted LC traces just outside the standard UV signatures—so we recalibrated our detection protocols and added extra rounds of purification as an SOP for high-purity batches. That drive to integrate real lab feedback often determines whether discovery work hits a roadblock or pushes ahead.
Years in the business taught us harsh lessons about transport and storage. During one hot summer, a regional power outage subjected inventory to above-normal temperatures; crystalline product lost form and purity, and perimeter testing failed to flag degradation quickly enough. Ever since, we enforce redundancy in supply chain tracking, install real-time monitoring of warehouse storage, and review shipping carriers’ ambient control credentials before committing to contracts. These precautions grew from lived experience, not simply reading industry best practices.
Adapting to new research needs takes more than reading journal articles. Green initiatives in chemical manufacturing, shifts in preferred solvent systems, and pharmaceutical client requests for nitrosamine-free status placed pressure on suppliers. We track such needs directly, adjusting process chemistry or cleaning protocols to keep downstream users in compliance with their markets.
Research environments run in cycles; pharmaceutical projects, catalyst screening campaigns, and materials synthesis all create surges and lulls in demand. A trader or third-party source can disappear from a market, but as direct manufacturers, we keep base inventory on-hand and maintain process flexibility to scale without compromising integrity.
We routinely review solvent recovery loops, effluent treatment facilities, and employee safety protocols. These efforts aren’t simply about branding; they affect every production batch, reducing potential cross-contamination and improving the traceability demanded during regulatory audits.
In the early days, teaching new operators about the compound meant demonstrating its handling, troubleshooting stuck washes, and evolving safety protocols. Experience proved that it takes a consistent team, feedback-driven process optimization, and up-to-date equipment to keep meeting researcher needs as projects evolve.
Researchers depend on a level of reliability that books and publications rarely mention. Production faults crop up—thermal mishaps, periods of reagent scarcity, force majeure events. The in-house processes and direct relationships with stakeholders spell the difference between uninterrupted research and meeting missed deadlines. Small impurities can derail entire research tracks; solubility changes snag automation runs; shifts in supply timing put regulatory filings in jeopardy.
Our knowledge pool combines decades of direct synthesis, troubleshooting, and fielding client concerns, which serve as the core metrics shaping our product. Rather than chasing trends or relabeling off-market stocks, we maintain knowledgeable staff on the floor, from shift chemists to analytical leads. Quick relabeling or shifting formulation sources—common among onward sellers—doesn’t play into our model. The path from raw materials to packaged product follows a single chain, observed every step.
We know labs frequently encounter setup challenges: inconsistent reactivity from similar building blocks, poor filtration in scale-ups, or surprising color shifts during workup. More than once, a development team needed guidance on dissolving the product efficiently in methanol or DMSO without destructive heating. Our approach addresses these needs with direct input, offering practical handling support, recovery tips, and insight into optimizing for specific end reactions.
The compound’s acid functionality handles standard reaction conditions for amidation or coupling, while the fused heterocycles enhance selectivity for next-generation ligand development. Our long-term supply contracts with established research institutions reflect this performance. We see chemistry as a collaborative undertaking by improving process robustness, custom packaging, or shipping stability according to feedback, not just to tick off an ISO-certified process.
Reliable chemical manufacturing isn’t about automated instruments alone. Our product runs through in-process checks for color, particle size, pH, and melting point on every lot. LC-MS analysis pinpoints trace side-products or degradation that might fly under the radar during mass-scale synthesis. For critical lots, we test for residual solvents—timed to catch issues at the source, not weeks later during customer troubleshooting. Each batch spends time in quarantine until cross-department sign-off, reducing field failures and ensuring traceability back to the raw material source.
Having encountered “too pure” lots (stripped of stabilizing traces), we learned long ago to balance stripping away all residues with retaining the subtle chemical stability needed for reactive applications. Real-world input shaped our specifications more than any regulatory body: NMR clean-up, color homogeneity, rapid dissolution, and safety documentation have become the minimum expected, not aspirational extras.
Global markets tighten their oversight on impurity profiles, supply verification, and eco-sustainability. We adapt daily, refining equipment, updating waste treatment, and keeping abreast of regulator demands—especially as trace nitrosamines, previously unregulated, are now under scrutiny in pharmaceutical and specialty chemical supply. Beyond limiting legal risk, these audits promote safer R&D environments. Regulations force us, not just to tick compliance boxes, but to genuinely improve reproducibility batch-to-batch.
That responsiveness is directly traceable to our place as the original manufacturer. Outsourced traders cannot backtrack or answer specific questions on batch handling quirks or upstream synthesis anomalies. Small research teams or industrial development managers benefit directly from a contact who committed energy to each stage, and signs off on every specification met, not just those that are convenient to measure.
6-(1H-imidazol-1-yl)pyridine-3-carboxylic acid doesn’t ride on name recognition alone. Its growing track record comes, in part, from our internal commitment to process adaption, clear communication with users, and direct accountability for every order that leaves our site. With each ton processed, lessons mount: how to avoid just-in-time disruption, predict regulatory shifts, and respond to research needs before they become full lab standstills.
Manufacturing remains an ongoing conversation with researchers, industrial formulators, and field chemists willing to share results—good or bad—on each lot. Such feedback improves our fundamentals with every batch, making it possible to steadily increase performance, lower costs, and keep chemistry advancing at the bench and beyond.